Published in J Orthop Traumatol on December 07, 2012
Non-operative vs. percutaneous stabilization in Magerl's A1 or A2 thoracolumbar spine fracture in adults: is it really advantageous for a good alignment of the spine? Preliminary data from a prospective study. Eur Spine J (2014) 0.77
Pharmacological prevention of venous thromboembolism in orthopaedic surgery. Clin Cases Miner Bone Metab (2014) 0.77
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
Reduction of postoperative mortality and morbidity with epidural or spinal anaesthesia: results from overview of randomised trials. BMJ (2000) 7.36
Effect of postoperative analgesia on surgical outcome. Br J Anaesth (2001) 2.85
Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Ann Intern Med (2008) 2.85
Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-leg immobilization. Cochrane Database Syst Rev (2008) 2.37
An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study. Arch Intern Med (2000) 2.28
Thrombosis risk assessment as a guide to quality patient care. Dis Mon (2005) 2.13
Incidence and risk factors for venous thromboembolic disease in podiatric surgery. Chest (2008) 2.09
Perioperative morbidity in patients randomized to epidural or general anesthesia for lower extremity vascular surgery. Perioperative Ischemia Randomized Anesthesia Trial Study Group. Anesthesiology (1993) 1.87
Guidelines on the assessment of bleeding risk prior to surgery or invasive procedures. British Committee for Standards in Haematology. Br J Haematol (2008) 1.80
Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest (2010) 1.67
The effects of local anesthetics on perioperative coagulation, inflammation, and microcirculation. Anesth Analg (2002) 1.66
Prevalence and risk factors for symptomatic thromboembolic events after shoulder arthroplasty. Clin Orthop Relat Res (2006) 1.55
Does regional anaesthesia improve outcome after total hip arthroplasty? A systematic review. Br J Anaesth (2009) 1.54
Effect of injury severity on the incidence and utilization-related outcomes of venous thromboembolism in pediatric trauma inpatients. Pediatr Crit Care Med (2009) 1.52
Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery. J Thromb Haemost (2009) 1.52
[Thromboprophylaxis is indicated for knee arthroscopy and cast immobilisation]. Ned Tijdschr Geneeskd (2007) 1.51
International normalized ratio and prothrombin time values before the removal of a lumbar plexus catheter in patients receiving warfarin after total hip replacement. Br J Anaesth (2008) 1.41
Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients. Thromb Haemost (2005) 1.27
Venous thromboembolic events are rare after shoulder surgery: analysis of a national database. J Shoulder Elbow Surg (2011) 1.26
The pneumatic tourniquet: mechanical, ischaemia-reperfusion and systemic effects. Eur J Anaesthesiol (2011) 1.21
Incidence and risk factors for venous thromboembolism in critically ill children after trauma. J Trauma (2010) 1.14
Deep venous thrombosis and anaesthesia. Br J Anaesth (1991) 1.13
Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am (2010) 1.13
Effects of epidural anesthesia on the incidence of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg Am (1991) 1.10
Effect of a continuous peripheral nerve block on the inflammatory response in knee arthroplasty. Reg Anesth Pain Med (2007) 1.10
The prevalence of risk factors for venous thromboembolism among hospital patients. Arch Intern Med (1992) 1.02
Prevention of venous thromboembolism in patients with immobilization of the lower extremities: a meta-analysis of randomized controlled trials. J Thromb Haemost (2008) 1.00
Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy. Thromb Haemost (2001) 0.98
Thromboembolic complications in patients with pelvic trauma. Clin Orthop Relat Res (1996) 0.97
Deep vein thrombosis in elderly patients hospitalized in subacute care facilities: a multicenter cross-sectional study of risk factors, prophylaxis, and prevalence. Arch Intern Med (2003) 0.96
The prevalence of and specific risk factors for venous thromboembolic disease following elective spine surgery. J Bone Joint Surg Am (2010) 0.96
Deep vein thromboembolism after arthroscopy of the shoulder: two case reports and a review of the literature. BMC Musculoskelet Disord (2010) 0.94
Venous thromboembolism in lower extremity arthroscopy. Arthroscopy (2008) 0.94
An evidence-based clinical guideline for the use of antithrombotic therapies in spine surgery. Spine J (2009) 0.94
Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery. J Orthop Traumatol (2011) 0.93
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy. Cochrane Database Syst Rev (2008) 0.93
Thromboembolic disease after total hip arthroplasty: who is at risk? Clin Orthop Relat Res (2006) 0.93
Venous thromboembolic events in pediatric trauma patients: is prophylaxis necessary? J Trauma (2005) 0.93
Thromboprophylaxis in patients with lower limb immobilisation - review of current status. Br J Haematol (2009) 0.88
Incidence of venous thromboembolic disease following hip arthroscopy. Orthopedics (2010) 0.87
Bupivacaine inhibits whole blood coagulation in vitro. Reg Anesth Pain Med (1999) 0.87
Incidence of deep vein thrombosis and pulmonary embolus following periacetabular osteotomy. J Bone Joint Surg Am (2011) 0.85
Altered venous function and deep venous thrombosis following proximal femoral fracture. Injury (2002) 0.84
A systematic review of thromboprophylaxis for pelvic and acetabular fractures. J Orthop Trauma (2009) 0.82
Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient. Med Clin North Am (1987) 0.80
Risk assessment of venous thromboembolism in hospitalized medical patients. Curr Opin Pulm Med (2010) 0.79
Early postoperative bleeding in polytrauma patients treated with fondaparinux: literature review and institutional experience. Curr Vasc Pharmacol (2011) 0.79
Lower thrombosis risk with epidural blockade in knee arthroplasty. Acta Orthop Scand (1990) 0.79
Thromboembolism following foot and ankle surgery: a case series and literature review. J Foot Ankle Surg (2008) 0.79
Effect of different anesthesia techniques on red blood cell endogenous recovery in hip arthroplasty. J Clin Anesth (2005) 0.78
Contralateral deep venous thrombosis after hip arthroscopy. Orthopedics (2011) 0.78
In vitro effects of local anaesthetics on the thromboelastographic profile of parturients. Br J Anaesth (2004) 0.77
Current trends in thromboprophylaxis in surgery of the foot and ankle. Foot Ankle Int (2007) 0.77
Balancing the risks and benefits of thromboprophylaxis in patients undergoing podiatric surgery. Chest (2009) 0.77
Does prior administration of enoxaparin influence the effects of levobupivacaine on blood clotting? Assessment using the Thrombelastograph. Br J Anaesth (2001) 0.76
Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. Evidence exists to guide thromboembolic prophylaxis in ambulatory patients with temporary lower limb immobilisation. Emerg Med J (2011) 0.76
Thromboembolic prophylaxis in foot and ankle surgery what should we do? Foot Ankle Spec (2011) 0.76
Acute venous thromboembolism after non-major orthopaedic surgery or post-traumatic limb immobilisation. Findings from the RIETE registry. Thromb Haemost (2011) 0.76
Ability of whole blood aggregometer to detect platelet hyperaggregability. Am J Clin Pathol (1989) 3.30
Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry. Am J Med (1996) 2.51
High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm. J Vasc Surg (2000) 2.27
Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost (2005) 2.13
The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study. J Thromb Haemost (2013) 2.05
A survey of thrombosis prophylaxis use in patients undergoing arthroscopic surgery. J Thromb Haemost (2004) 2.05
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results. J Thromb Haemost (2012) 2.04
Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study. EMSALT Study Group. Lancet (2000) 1.95
Different methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patients. J Thromb Haemost (2007) 1.91
Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study. Intensive Care Med (1998) 1.90
Recommendations for airway control and difficult airway management in thoracic anesthesia and lung separation procedures. Minerva Anestesiol (2008) 1.71
Postoperative pain treatment SIAARTI Recommendations 2010. Short version. Minerva Anestesiol (2010) 1.70
Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost (2001) 1.55
Cirrhosis of the liver. A risk factor for development of cholelithiasis in males. Dig Dis Sci (1990) 1.48
Outcome research and patient-oriented measures in the multiperspective assessment of neurological and musculoskeletal disorders. Consensus Conference: Third Roman Neurophysiology Day, Outcome Research in Neurology and in Musculoskeletal Disorders--24 October 1998. Ital J Neurol Sci (1999) 1.47
Prevalence of factor V Leiden mutation in non-European populations. Thromb Haemost (1997) 1.45
Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost (2004) 1.44
Preimplantation retrograde pneumoplegia in clinical lung transplantation. J Thorac Cardiovasc Surg (1999) 1.44
Percutaneous transluminal coronary angioplasty procedure is associated to a decrease in transforming growth factor beta 1 levels. Thromb Haemost (1999) 1.42
Pilot double-blinded study to assess efficacy and tolerability of morphine sulphate oral solution (Oramorph®) given preoperatively as add-on therapy within a multimodal postoperative pain approach in patients undergoing laparoscopic cholecystectomy. Minerva Anestesiol (2014) 1.40
Activated protein C resistance: a comparison between two clotting assays and their relationship to the presence of the factor V Leiden mutation. Br J Haematol (1996) 1.39
The role of cysteine and homocysteine in venous and arterial thrombotic disease. Am J Clin Pathol (2001) 1.38
High cysteine levels in renal transplant recipients: relationship with hyperhomocysteinemia and 5,10-MTHFR polymorphism. Transplantation (2001) 1.38
Italian version of the Disability of the Arm, Shoulder and Hand (DASH) questionnaire. Cross-cultural adaptation and validation. J Hand Surg Br (2003) 1.32
Thrombotic events during oral anticoagulant treatment: results of the inception-cohort, prospective, collaborative ISCOAT study: ISCOAT study group (Italian Study on Complications of Oral Anticoagulant Therapy). Thromb Haemost (1997) 1.27
Activated protein C resistance in deep-vein thrombosis. Lancet (1994) 1.22
Effects of ultrasound guidance on the minimum effective anaesthetic volume required to block the femoral nerve. Br J Anaesth (2007) 1.20
Patient outcomes after Harrington instrumentation for idiopathic scoliosis: a 15- to 28-year evaluation. Spine (Phila Pa 1976) (2001) 1.20
Acute T-cell activation is detectable in unstable angina. Circulation (1997) 1.19
Prevalence and clinical history of incidental, asymptomatic pulmonary embolism: a meta-analysis. Thromb Res (2010) 1.18
Small doses of remifentanil or sufentanil for blunting cardiovascular changes induced by tracheal intubation: a double-blind comparison. Eur J Anaesthesiol (2001) 1.17
Activation of extracellular signal-regulated kinase in human prostate cancer. J Urol (1999) 1.12
Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH). J Thromb Haemost (2012) 1.11
Video-assisted thoracoscopic treatment of giant bullae associated with emphysema. Eur J Cardiothorac Surg (1999) 1.10
Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss. J Thromb Haemost (2005) 1.09
Clinical and neurological abnormalities in adult celiac disease. Neurol Sci (2003) 1.08
Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Circulation (2009) 1.07
Effect of computer-aided management on the quality of treatment in anticoagulated patients: a prospective, randomized, multicenter trial of APROAT (Automated PRogram for Oral Anticoagulant Treatment). Haematologica (2001) 1.06
Questions and answers on the use of dabigatran and perspectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA). Thromb Haemost (2011) 1.06
Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. J Thromb Haemost (2010) 1.06
Hemostatic abnormalities in inflammatory bowel disease. Thromb Res (1996) 1.05
Lessons learned searching for a HRQoL instrument to assess the results of treatment in persons with lumbar disorders. Spine (Phila Pa 1976) (2000) 1.05
Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance: a multicenter collaborative family study. Arterioscler Thromb Vasc Biol (1999) 1.05
High thrombin generation measured in the presence of thrombomodulin is associated with an increased risk of recurrent venous thromboembolism. J Thromb Haemost (2008) 1.04
Permanent Genetic Resources added to Molecular Ecology Resources database 1 January 2009-30 April 2009. Mol Ecol Resour (2009) 1.04
Physiologic role of coronary PGI2 and PGE2 in modulating coronary vascular response to sympathetic stimulation. Am Heart J (1990) 1.02
Oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and risk of bleeding. A Multicenter Inception Cohort Study. Thromb Haemost (2001) 1.02
Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thromb Haemost (1998) 1.02
The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-gamma-carboxy prothrombin. Liver Transpl Surg (1995) 1.01
An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. J Thromb Haemost (2008) 1.00
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost (2012) 0.99
Thymectomy for myasthenia gravis: a 27-year experience. Eur J Cardiothorac Surg (1999) 0.99
Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10-methylenetetrahydrofolate reductase. Am J Hum Genet (1998) 0.99
Ten- to 15-year outcome of surgery for lumbar disc herniation: radiographic instability and clinical findings. Eur Spine J (1999) 0.98
Angiotensin-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinemia increase first-trimester fetal-loss susceptibility. Blood Coagul Fibrinolysis (2000) 0.96
Value of family history in identifying women at risk of venous thromboembolism during oral contraception: observational study. BMJ (2001) 0.96
Evaluation of new laryngoscope blade for tracheal intubation, Truview EVO2: a manikin study. Eur J Anaesthesiol (2008) 0.95
Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery. J Orthop Traumatol (2011) 0.93
Tracheal compression caused by oversized i-gel in children. Minerva Anestesiol (2012) 0.93
The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD). Thromb Haemost (1998) 0.93
Hyperhomocyst(e)inemia and a common methylenetetrahydrofolate reductase mutation (Ala223Val MTHFR) in patients with inherited thrombophilic coagulation defects. Arterioscler Thromb Vasc Biol (1997) 0.92
Italian version of the Roland Disability Questionnaire, specific for low back pain: cross-cultural adaptation and validation. Eur Spine J (2001) 0.92
Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study. Int Angiol (2009) 0.92
D-dimer plasma levels during normal pregnancy measured by specific ELISA. Int J Clin Lab Res (1997) 0.92
The Italian version of the Oxford 12-item Knee Questionnaire-cross-cultural adaptation and validation. Int Orthop (2003) 0.92
Pulmonary hypertension associated with long-standing thrombocytosis. Chest (1991) 0.91
D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis. Thromb Haemost (2011) 0.91
Age-related changes in the hemostatic system. Int J Clin Lab Res (1993) 0.91
Carpal tunnel syndrome: indication for surgical treatment based on electrophysiologic study. J Hand Surg Am (1998) 0.90
The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. Arterioscler Thromb Vasc Biol (1997) 0.89
Atherosclerotic and thrombophilic risk factors in patients with recurrent central retinal vein occlusion. Eur J Ophthalmol (2008) 0.89
Incidence of gallstones in a population of patients with cirrhosis. J Hepatol (1994) 0.89
Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting. J Thromb Haemost (2010) 0.89
Clinical histories and molecular characterization of two afibrinogenemic patients: insights into clinical management. Haemophilia (2011) 0.89
World distribution of the T833C/844INS68 CBS in cis double mutation: a reliable anthropological marker. Hum Genet (1999) 0.88
Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study. Eur J Vasc Endovasc Surg (2010) 0.88
Combination of D-dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal. J Thromb Haemost (2008) 0.88
Renal transplant recipients are at high risk for both symptomatic and asymptomatic deep vein thrombosis. J Thromb Haemost (2006) 0.87
Combined sciatic-femoral nerve block with 0.75% ropivacaine: effects of adding a systemically inactive dose of fentanyl. Eur J Anaesthesiol (2000) 0.87
Cross-cultural adaptation of the lumbar North American Spine Society questionnaire for Italian-speaking patients with lumbar spinal disease. Spine (Phila Pa 1976) (2001) 0.87
Blood clotting activation during normal pregnancy. Thromb Res (1996) 0.87
Evaluation of the debonding strength of orthodontic brackets using three different bonding systems. Eur J Orthod (2007) 0.86
Cerebellar vermis hypoplasia in a case of cri-du-chat syndrome. Acta Neurol (Napoli) (1993) 0.86
Hereditary thrombophilia and fetal loss: a prospective follow-up study. J Thromb Haemost (2004) 0.86
D-dimer levels and 15-day outcome in acute pulmonary embolism. Findings from the RIETE Registry. J Thromb Haemost (2009) 0.86
Efficacy of functional hemodynamic parameters in predicting fluid responsiveness with pulse power analysis in surgical patients. Minerva Anestesiol (2012) 0.86
More on: high thrombin generation and the risk of recurrent venous thromboembolism. J Thromb Haemost (2009) 0.86
Knowledge of residual curarization: an Italian survey. Acta Anaesthesiol Scand (2009) 0.85
Retrievable vena cava filters: key considerations. Thromb Res (2007) 0.85
Comparison of new rapid methods for D-dimer measurement to exclude deep vein thrombosis in symptomatic outpatients. Blood Coagul Fibrinolysis (1997) 0.85
Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination. Blood Coagul Fibrinolysis (2002) 0.85
Limits and pitfalls of haemodynamic monitoring systems in liver transplantation surgery. Minerva Anestesiol (2012) 0.84
Markers of procoagulant imbalance in patients with inherited thrombophilic syndromes. Thromb Haemost (1992) 0.84
Cytokine gene expression in human LPS- and IFNgamma-stimulated mononuclear cells is inhibited by heparin. Thromb Haemost (1998) 0.84
D-dimer testing: advantages and limitations in emergency medicine for managing acute venous thromboembolism. Intern Emerg Med (2007) 0.84